Dana O’Brien is the executive vice president of food & agriculture at Biotechnology Innovation Organization (BIO) and in this piece he shares his thoughts on improving the regulatory system for animal biotechnology.
The Food and Drug Administration says that a new analysis indicating genome editing in cattle can have unintended consequences underscores the importance of its regulatory approach to animal biotechnology.
Trade remains the top concern for American agriculture heading into 2020, with looming uncertainty about whether the Chinese will make promised increases in commodity purchases, and whether President Donald Trump will provide another round of trade assistance to U.S. producers.
Lawmakers are trying to wrap up deals this week on the U.S.-Mexico-Canada Agreement and fiscal 2020 government spending while the Trump administration faces a self-imposed deadline for getting a partial trade agreement with China.
Alfredo Gutierrez is an agronomist and fifth-generation dairy farmer in the central region of Mexico, where he is in charge of animal health and nutrition, equipment, technology, and crop production. In this opinion piece, he discusses the repercussions of blocking glyphosate.
Nearly a year after the 2018 farm bill legalized industrial hemp production, the business community continues to seek answers to questions about testing and marketing of products derived from the crop, the commercial potential of which has sparked interest throughout the country.
The Senate is looking to finish work on a package of spending bills funding USDA and other agencies important to agriculture, but it increasingly appears that Congress won’t reach a final agreement on fiscal 2020 until after the first of the year.